Burning Historical Financial Ratios
BNR Stock | USD 6.67 0.07 1.04% |
Burning Rock is presently reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.0 or Days Sales Outstanding of 82.01 will help investors to properly organize and evaluate Burning Rock Biotech financial condition quickly.
Burning |
About Burning Financial Ratios Analysis
Burning Rock BiotechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Burning Rock investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Burning financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Burning Rock history.
Burning Rock Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Burning Rock Biotech stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Burning Rock sales, a figure that is much harder to manipulate than other Burning Rock Biotech multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Burning Rock's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Burning Rock Biotech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Burning Rock's Tangible Book Value Per Share is relatively stable compared to the past year. As of 01/30/2025, Receivables Turnover is likely to grow to 4.15, while PTB Ratio is likely to drop 1.00.
2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 3.6 | 9.65 | 8.68 | 9.12 | Days Of Inventory On Hand | 259.65 | 144.61 | 130.15 | 174.29 |
Burning Rock fundamentals Correlations
Click cells to compare fundamentals
Burning Rock Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Burning Rock fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 240.64 | 124.21 | 28.63 | 1.31 | 1.51 | 1.43 | |
Ptb Ratio | 42.73 | 34.19 | 13.92 | 0.92 | 1.05 | 1.0 | |
Days Sales Outstanding | 94.03 | 116.02 | 110.32 | 113.97 | 102.57 | 82.01 | |
Book Value Per Share | 35.27 | 17.71 | 11.15 | 75.04 | 67.54 | 70.92 | |
Free Cash Flow Yield | (0.00148) | (0.011) | (0.0322) | (0.38) | (0.43) | (0.41) | |
Operating Cash Flow Per Share | (1.07) | (4.59) | (4.4) | (24.98) | (28.73) | (27.29) | |
Stock Based Compensation To Revenue | 0.4 | 0.56 | 0.58 | 0.49 | 0.44 | 0.25 | |
Capex To Depreciation | 2.39 | 4.47 | 0.5 | 0.0703 | 0.0809 | 0.0769 | |
Pb Ratio | 42.73 | 34.19 | 13.92 | 0.92 | 1.05 | 1.0 | |
Ev To Sales | 236.34 | 121.56 | 27.11 | 0.19 | 0.22 | 0.21 | |
Free Cash Flow Per Share | (2.23) | (6.63) | (4.99) | (25.9) | (29.78) | (28.29) | |
Roic | (0.15) | (0.41) | (0.81) | (0.86) | (0.98) | (1.03) | |
Inventory Turnover | 1.71 | 1.17 | 1.41 | 2.52 | 2.9 | 1.97 | |
Net Income Per Share | (5.44) | (7.65) | (9.35) | (63.84) | (73.41) | (69.74) | |
Days Of Inventory On Hand | 214.07 | 312.92 | 259.65 | 144.61 | 130.15 | 174.29 | |
Payables Turnover | 3.27 | 2.28 | 3.6 | 9.65 | 8.68 | 9.12 | |
Research And Ddevelopement To Revenue | 0.61 | 0.72 | 0.75 | 0.65 | 0.58 | 0.46 | |
Capex To Revenue | 0.19 | 0.42 | 0.11 | 0.0175 | 0.0201 | 0.0191 | |
Cash Per Share | 32.89 | 14.35 | 8.73 | 60.07 | 54.06 | 56.77 | |
Pocfratio | (1.4K) | (132.0) | (35.3) | (2.75) | (2.48) | (2.6) | |
Capex To Operating Cash Flow | (1.08) | (0.45) | (0.14) | (0.0367) | (0.033) | (0.0347) | |
Pfcf Ratio | (675.79) | (91.25) | (31.08) | (2.66) | (2.39) | (2.51) | |
Days Payables Outstanding | 111.66 | 160.21 | 101.51 | 37.84 | 43.52 | 41.34 | |
Income Quality | 0.18 | 0.6 | 0.47 | 0.39 | 0.45 | 0.76 | |
Roe | (0.15) | (0.43) | (0.84) | (0.85) | (0.98) | (0.93) | |
Ev To Operating Cash Flow | (1.4K) | (129.19) | (33.43) | (0.4) | (0.36) | (0.37) | |
Pe Ratio | (276.82) | (79.18) | (16.6) | (1.08) | (0.97) | (1.02) | |
Return On Tangible Assets | (0.14) | (0.35) | (0.61) | (0.63) | (0.72) | (0.76) | |
Ev To Free Cash Flow | (663.71) | (89.3) | (29.43) | (0.38) | (0.34) | (0.36) | |
Earnings Yield | (0.003612) | (0.0126) | (0.0602) | (0.93) | (1.07) | (1.01) | |
Intangibles To Total Assets | 0.001298 | 0.00226 | 0.001251 | 9.27E-4 | 8.34E-4 | 9.97E-4 | |
Net Debt To E B I T D A | 4.95 | 1.8 | 1.0 | 1.12 | 1.01 | 0.75 | |
Current Ratio | 10.45 | 4.89 | 3.06 | 3.36 | 3.02 | 3.54 | |
Tangible Book Value Per Share | 35.22 | 17.66 | 11.13 | 74.95 | 67.45 | 70.83 | |
Receivables Turnover | 3.88 | 3.15 | 3.31 | 3.2 | 3.68 | 4.15 | |
Graham Number | 65.74 | 55.19 | 48.42 | 328.31 | 295.48 | 310.26 | |
Shareholders Equity Per Share | 35.27 | 17.71 | 11.15 | 75.04 | 67.54 | 70.92 | |
Debt To Equity | 0.0194 | 0.047 | 0.0438 | 0.016 | 0.0184 | 0.0175 |
Pair Trading with Burning Rock
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burning Rock position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will appreciate offsetting losses from the drop in the long position's value.Moving against Burning Stock
0.89 | PDSB | PDS Biotechnology Corp | PairCorr |
0.86 | JNJ | Johnson Johnson | PairCorr |
0.85 | NKTX | Nkarta Inc | PairCorr |
0.78 | INZY | Inozyme Pharma | PairCorr |
0.69 | MREO | Mereo BioPharma Group | PairCorr |
The ability to find closely correlated positions to Burning Rock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burning Rock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burning Rock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burning Rock Biotech to buy it.
The correlation of Burning Rock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burning Rock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burning Rock Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burning Rock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Burning Stock Analysis
When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.